Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synthematix was a chemistry informatics company that provided software solutions designed to streamline and automate the drug discovery process. The company's flagship product, the Arthur suite, offered tools for reaction planning, electronic laboratory notebooks (ELN), and data management specifically tailored for synthetic and medicinal chemists. By integrating chemical information with experimental data, Synthematix aimed to improve the efficiency of lead optimization and library design. The company was acquired by Symyx Technologies in 2005 to bolster their electronic lab notebook and decision-support offerings. Its technology eventually became part of the BIOVIA brand under Dassault Systèmes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synthematix.